Prevalent OPG and RANKL Excession in Patients With CAD
1 clinical trials · Condition
◉ Watch Prevalent OPG and RANKL Excession in Patients With CAD
| Record | Firm | Date |
|---|---|---|
| Graz Osteoprotegerin as a Risk Factor (GORF) Study (NCT01574963) | Medical University of Graz | 2010-07-01 |
Track Prevalent OPG and RANKL Excession in Patients With CAD automatically
Every clearance here is in the API, with alerts when new ones post.